Vascular tone and the genomics of hypertension

Heart Failure Clinics
Richard Sheppard

Abstract

Hypertension is a common condition that is a well-described risk factor for the development of cerebrovascular disease, myocardial infarction and heart failure. Medical therapy for hypertension may not only prevent development of these potentially devastating illnesses but may be used to treat high blood pressure, which coexists with these conditions. Therapeutic response to medical therapy for hypertension is variable and may be related to the individual genetic profile of patients. We have described here only several of the HTN-related polymorphisms that may impact clinical response in patients who have high blood pressure and coexisting conditions. Future studies are needed to identify other potential genotypes that may influence therapeutic response in addition to clinical trials of specific medical therapy in individual patients based on specific genotypes.

References

Jul 15, 1992·Proceedings of the National Academy of Sciences of the United States of America·T MorisakiE W Holmes
Dec 1, 1991·European Heart Journal·T KurzP B Corr
May 1, 1990·Hypertension·M ShichiriF Marumo
Jun 1, 1990·The American Journal of Medicine·M KohnoT Takeda
Jan 1, 1987·Hypertension·W A Pettinger
Dec 30, 1993·The New England Journal of Medicine·S Moncada, A Higgs
Apr 1, 1995·American Journal of Hypertension·W LocketteL Cadaret
Jun 1, 1993·Hypertension·D E HandyH Gavras
Jun 15, 1994·Biochemical and Biophysical Research Communications·N XuJ S Gutkind
Jan 1, 1993·Annual Review of Pharmacology and Toxicology·R R RuffoloJ P Hieble
Apr 1, 1994·Circulation·C M WeiJ C Burnett
Nov 12, 1996·Proceedings of the National Academy of Sciences of the United States of America·E G SheselyO Smithies
Jan 13, 1998·Nature Genetics·W SiffertB Horsthemke
Apr 30, 1998·Journal of the American College of Cardiology·L GregoriniA Zanchetti
Jul 17, 1998·Circulation·C P TiefenbacherW M Chilian
Aug 26, 1998·Proceedings of the National Academy of Sciences of the United States of America·J W AdamsG W Dorn
Dec 30, 1998·Journal of Cardiovascular Pharmacology·N Fajardo, Y Deshaies
Mar 23, 2000·Cardiovascular Research·K SinghW S Colucci
Sep 12, 2000·American Journal of Hypertension·A V Benjafield, B J Morris
Oct 12, 2000·Journal of the American College of Cardiology·J L AndersonN Hart
Feb 24, 2001·Circulation·F ElijovichE L Schiffrin
Mar 27, 2001·Annual Review of Pharmacology and Toxicology·R M Kedzierski, M Yanagisawa

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.

Adrenergic Receptors: Trafficking

Adrenergic receptor trafficking is an active physiological process where adrenergic receptors are relocated from one region of the cell to another or from one type of cell to another. Discover the latest research on adrenergic receptor trafficking here.

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.

Brain Ischemia

Brain ischemia is a condition in which there is insufficient blood flow to the brain to meet metabolic demand. Discover the latest research on brain ischemia here.

Cardiomyopathy

Cardiomyopathy is a disease of the heart muscle, that can lead to muscular or electrical dysfunction of the heart. It is often an irreversible disease that is associated with a poor prognosis. There are different causes and classifications of cardiomyopathies. Here are the latest discoveries pertaining to this disease.